Mobile
Search
Advanced search
Multi-criteria search
Who are we ?
Log in
Sign up
Français
English
Kusajili – Clinical trials directory
Send this study to a contact
1
Your personal information
Your name
Your e-mail
Send me a copy
2
Your recipient's information
The name of your contact
Your contact email
3
Your message
Votre message
A multi-centre, randomised, double-blinded, controlled, dose-escalation trial on safety and efficacy of activated recombinant FVII analogue (NN1731) in the treatment of joint bleeds in congenital haemophilia patients with inhibitors.Trial phase: 2 https://kusajili.fr:443/Trial/BUbKe5cHEUahU0E59B_qdg%24a-multi-centre-randomised-double-blinded-controlled-dose-escalation-trial-on-safety-and-efficacy-of-activated-recombinant-fvii-
I have read and accept the terms of use of the site and the Privacy Policy
Send your message